APH vs CV · P/E 40, rev $23.09B vs rev $3.5M
Amphenol Corporation (APH) versus CapsoVision, Inc. Common Stock (CV) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. CV currently screens at market cap $359.2M.
Not investment advice. Open the APH and CV stock pages for the full models.
Not investment advice.